danthron has been researched along with Metabolic Diseases in 1 studies
danthron: structure
chrysazin : A dihydroxyanthraquinone that is anthracene-9,10-dione substituted by hydroxy groups at positions 1 and 8.
Metabolic Diseases: Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (METABOLISM, INBORN ERRORS) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (Stedman, 26th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ma, C | 1 |
| Wang, Z | 1 |
| Xia, R | 1 |
| Wei, L | 1 |
| Zhang, C | 1 |
| Zhang, J | 1 |
| Zhao, L | 1 |
| Wu, H | 1 |
| Kang, L | 1 |
| Yang, S | 1 |
1 other study available for danthron and Metabolic Diseases
| Article | Year |
|---|---|
Danthron ameliorates obesity and MAFLD through activating the interplay between PPARα/RXRα heterodimer and adiponectin receptor 2.
Topics: 3T3-L1 Cells; AMP-Activated Protein Kinases; Animals; Anthraquinones; Anti-Obesity Agents; Diet, Hig | 2021 |